Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: INCB9471
  • Price: $Inquiry/25mg $Inquiry/100mg $Inquiry/250mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

869769-98-2

869769-98-2 structure
869769-98-2 structure
  • Name: INCB9471
  • Chemical Name: INCB-9471
  • CAS Number: 869769-98-2
  • Molecular Formula: C30H40F3N5O2
  • Molecular Weight: 559.666
  • Create Date: 2020-01-20 09:19:57
  • Modify Date: 2024-04-09 17:22:11
  • A potent, selective and orally bioavailable CCR5 antagonist IC50 of 6.5 nM, Kd of 3.1 nM in human PBMCs; inhibits CCR5-mediated signaling events such as intracellular calcium mobilization, ERK phosphorylation, and CCR5 receptor internalization with IC50 values of 16, 3, and 1.5 nM, respectively; demonstrates anti-HIV-1 activity against R5 HIV-1 strains representing the major clades including A, B, C, D, E, F, G, and J with mean IC50 of 9 nM in PBMCs; also is a potent inhibitor of mutant HIV-1 variants that are resistant to other drugs including NRTIs, NNRTIs, PIs, and the fusion inhibitor T20. HIV Infection Phase 1 Clinical

Name INCB-9471
Synonyms C5D4W25708
(4,6-Dimethyl-5-pyrimidinyl)(4-{(3S)-4-[(1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methyl-1-piperazinyl}-4-methyl-1-piperidinyl)methanone
Methanone, (4,6-dimethyl-5-pyrimidinyl)[4-[(3S)-4-[(1R,2R)-2-ethoxy-2,3-dihydro-5-(trifluoromethyl)-1H-inden-1-yl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]-
INCB-9471
Description A potent, selective and orally bioavailable CCR5 antagonist IC50 of 6.5 nM, Kd of 3.1 nM in human PBMCs; inhibits CCR5-mediated signaling events such as intracellular calcium mobilization, ERK phosphorylation, and CCR5 receptor internalization with IC50 values of 16, 3, and 1.5 nM, respectively; demonstrates anti-HIV-1 activity against R5 HIV-1 strains representing the major clades including A, B, C, D, E, F, G, and J with mean IC50 of 9 nM in PBMCs; also is a potent inhibitor of mutant HIV-1 variants that are resistant to other drugs including NRTIs, NNRTIs, PIs, and the fusion inhibitor T20. HIV Infection Phase 1 Clinical
References References 1. Xue CB, et al. ACS Med Chem Lett. 2010 Aug 25;1(9):483-7. 2. Shin N, et al. J Pharmacol Exp Ther. 2011 Jul;338(1):228-39. View Related Products by Target Chemokine Receptor (CCR and CXCR) HIV Infection
Density 1.3±0.1 g/cm3
Boiling Point 639.2±55.0 °C at 760 mmHg
Molecular Formula C30H40F3N5O2
Molecular Weight 559.666
Flash Point 340.3±31.5 °C
Exact Mass 559.313416
LogP 2.63
Vapour Pressure 0.0±1.9 mmHg at 25°C
Index of Refraction 1.582